Pharmacological modulation of b-adrenoceptors as a new cardioprotective strategy for therapy of myocardial dysfunction induced by ischemia and reperfusion
Acta cir. bras; 34 (5), 2019
Publication year: 2019
Abstract Purpose:
To evaluate the cardioprotective response of the pharmacological modulation of β-adrenergic receptors (β-AR) in animal model of cardiac ischemia and reperfusion (CIR), in spontaneously hypertensive (SHR) and normotensive (NWR) rats.Methods:
CIR was induced by the occlusion of left anterior descendent coronary artery (10 min) and reperfusion (75 min). The SHR was treated with β-AR antagonist atenolol (AT, 10 mg/kg, IV) 5 min before CIR, and NWR were treated with β-AR agonist isoproterenol (ISO, 0.5 mg/kg, IV) 5 min before CIR.Results:
The treatment with AT increased the incidence of VA, AVB and LET in SHR, suggesting that spontaneous cardioprotection in hypertensive animals was abolished by blockade of β-AR. In contrast, the treatment with ISO significantly reduced the incidence of ventricular arrhythmia, atrioventricular blockade and lethality in NWR (30%, 20% and 20%, respectively), suggesting that the activation of β-AR stimulate cardioprotection in normotensive animals. Serum CK-MB were higher in SHR/CIR and NWR/CIR compared to respective SHAM group (not altered by treatment with AT or ISO).Conclusion:
The pharmacological modulation of β-AR could be a new cardioprotective strategy for the therapy of myocardial dysfunctions induced by CIR related to cardiac surgery and cardiovascular diseases.
Antagonistas de Receptores Adrenérgicos beta 1/farmacología, Agonistas Adrenérgicos beta/farmacología, Atenolol/farmacología, Biomarcadores/sangre, Presión Sanguínea/efectos de los fármacos, Cardiotónicos/farmacología, Forma MB de la Creatina-Quinasa/sangre, Pruebas de Función Cardíaca, Isoproterenol/farmacología, Daño por Reperfusión Miocárdica/sangre, Daño por Reperfusión Miocárdica/tratamiento farmacológico, Daño por Reperfusión Miocárdica/fisiopatología, Ratas Endogámicas SHR, Receptores Adrenérgicos beta/efectos de los fármacos, Reproducibilidad de los Resultados, Factores de Tiempo, Resultado del Tratamiento